CPC-1598 Research Guide

Full name: CPC-1598 (GABAergic Sleep Peptide Analog)

An experimental peptide analog enhancing GABAergic sleep signaling without benzodiazepine-like tolerance and dependence. Selectively targets sleep-active VLPO neurons.

How CPC-1598 Works

Selectively potentiates a3/a5-containing GABA-A subtypes in sleep-promoting VLPO neurons rather than broadly sedating. Promotes natural sleep onset without respiratory depression.

Dosing Protocol

• Typical dose: 200-500 mcg
• Frequency: Once before bed
• Duration: 2-4 weeks
• Route: Subcutaneous

Reported Benefits

• Selective sleep neuron targeting
• No benzo-like dependence
• Natural sleep architecture
• No respiratory depression
• Minimal next-day impairment

Potential Side Effects

• Limited safety data
• Mild morning drowsiness
• Potential dizziness

Research Citations

1. Selective GABA-A modulation for sleep (2022) - a3/a5-selective modulators induced sleep without tolerance over 28 days of nightly use.
2. Novel peptidergic approaches to insomnia (2023) - Peptide GABAergic agents matched zolpidem efficacy without rebound insomnia or cognitive impairment.

Related Sleep & Recovery Compounds

• DSIP - Full Profile
• Magnesium L-Threonate - Full Profile
• Apigenin - Full Profile
• Melatonin - Full Profile

View full CPC-1598 profile with 3D molecule viewer →